SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/198756"
 

Search: onr:"swepub:oai:gup.ub.gu.se/198756" > Safety and tolerabi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial

Nitti, V W (author)
Chapple, C R (author)
Walters, C (author)
show more...
Blauwet, M B (author)
Herschorn, S (author)
Milsom, Ian, 1950 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology
Auerbach, S (author)
Radziszewski, P (author)
show less...
 (creator_code:org_t)
2014-04-06
2014
English.
In: International journal of clinical practice. - : Hindawi Limited. - 1742-1241 .- 1368-5031. ; 68:8, s. 972-985
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • To evaluate the safety and tolerability of the β3 -adrenoceptor agonist, mirabegron, in patients with overactive bladder (OAB).

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view